Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Chronic Opioid Use May be Common in Patients With Ankylosing Spondylitis

Key clinical point: Chronic opioid use may be common in patients with ankylosing spondylitis.

Major finding: Of those patients given the International Classification of Diseases (ICD) code 720.0, which is specific for ankylosing spondylitis, 23.5% of patients received at least a 90-day supply of opioids in a year.

Study details: The findings were noted in 2012-2017 data from a cohort of 11,945 patients in the Truven Health MarketScan Research database.

Disclosures: UCB Pharma funded the study. The authors are employees of UCB Pharma.


Sloan VS et al. J Rheumatol. 2019 Jan 15. doi: 10.3899/jrheum.180972.